drugset / Trial / NCT00000374
Treatment for First-Episode Schizophrenia
Phase 4
Completed
125 enrolled
Northwell Health
National Institute of Mental Health (NIMH) · collabThe Zucker Hillside Hospital · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.
Timeline
- Start
- 1998-09
- Primary completion
- 2007-05
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 2.5 mg | — |
| Subject | Olanzapine | Small molecule | 20 mg | — |
| Subject | Risperidone | Other / unclassified | 1 mg | — |
| Subject | Risperidone | Other / unclassified | 6 mg | — |